Meiji Holdings Co., Ltd.: Business Overview, Financials & Competitive Analysis
Meiji Holdings Co., Ltd. scores 6/10 on the AskCyborg Cyborg Score (Solid). Solid dividend-paying dividend story leveraging global health trends and Asian market expansion potential, though near-term profitability faces cyclical cost pressures. Meiji demonstrates solid fundamentals with a diversified portfolio across food and pharmaceuticals, strong international expansion potential, and margin improvement initiatives. However, the company faces near-term headwinds from yen.
What is Meiji Holdings Co., Ltd.'s industry? Meiji Holdings Co., Ltd. (meiji.com) operates in Consumer Packaged Goods / Pharmaceuticals. AskCyborg classifies Meiji Holdings Co., Ltd. under Consumer Packaged Goods / Pharmaceuticals in its company registry.
Meiji Holdings is a diversified Japanese food and pharmaceutical conglomerate that manufactures and sells dairy products, confectionery, health foods, and pharmaceuticals domestically and internationally. As the world...
Cyborg Score thesis
Solid dividend-paying dividend story leveraging global health trends and Asian market expansion potential, though near-term...
Read the full analyst-debate transcript →Get the Latest Meiji Holdings Co., Ltd. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeMeiji Holdings Co., Ltd. Overview
Pro stress-test →Meiji Holdings is a diversified Japanese food and pharmaceutical conglomerate that manufactures and sells dairy products, confectionery, health foods, and pharmaceuticals domestically and internationally. As the world's fourth-largest confectionery company, Meiji leverages a century-old heritage and strong brand recognition to compete in consumer-packaged goods and pharmaceutical sectors.
Strategic Profile
Pro stress-test →The company derives approximately 80% of sales and 70% of profits from its food business (dairy, cacao, nutrition, and food solutions), with the remaining 20% from pharmaceuticals specializing in antibacterial drugs, generics, and vaccines. Meiji's competitive advantage rests on its strong brand recognition, extensive distribution network, and research-driven product innovation, positioning it to capture rising demand for health and functional foods in Asia while navigating margin pressures from currency fluctuations and input cost inflation.
Competitive Landscape
Pro stress-test →Meiji competes in mature confectionery and food markets against global players including Nestlé, General Mills, and Ezaki Glico, as well as regional competitors like Toyo Suisan Kaisha. The company's differentiation comes from heritage brand recognition, product innovation capabilities, and growing pharmaceutical and health food portfolios, though it faces structural headwinds in Japan's shrinking domestic market and rising competition in Asian expansion markets.
Industry Context
Meiji Holdings Co., Ltd. operates in Consumer Packaged Goods / Pharmaceuticals.
Key facts
Founded: 2009 · Headquarters: Tokyo, Japan · Employees: 17,231 · Revenue: $8.0B · Market cap: $6.8B